Related content

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li   Hu Cheng-Ping   Yang Hua-ping   Li Yuan-yuan   Gu Qi-hua   Wu Lielin  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite

Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation

By                    

International Journal of Oncology, Vol. 42, Iss. 6, 2013-01 ,pp. : 2094-2102

Spandidos Publications

Access to resources Recommend Favorite

Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers

By      

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1207-1212

Spandidos Publications

Access to resources Recommend Favorite

Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung

By Lee Youngjoo   Han Ji-Youn   Kim Heung   Yun Tak   Lee Geon   Kim Hyae   Lee Jin  

Journal of Neuro-Oncology, Vol. 115, Iss. 1, 2013-10 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

EGFR–tyrosine kinase mutation testing methods in non-small-cell lung cancer: new diagnostic guidance is NICE

By Wallace Andrew  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 449-451

Future Medicine

Access to resources Recommend Favorite